Sara Barulli
Impact in
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Dermatology top 5%
- Cutaneous lymphoproliferative disorders research
Papers in
-
- Lymphoma Diagnosis and Treatment 6
- Oncology 5
- Viral-associated cancers and disorders 2
- Co-authors
- Giuseppe Visani (8 shared papers)Alessandro Isidori (8 shared papers)Giovanni Barosi (1 shared paper)Marie‐Caroline Le Bousse‐Kerdilès (1 shared paper)Antonietta Falcone (1 shared paper)S Gentili (1 shared paper)Dominique Bordessoule (1 shared paper)Giuliano Brandozzi (2 shared papers)
In The Last Decade
Sara Barulli
12 papers receiving 268 citations
Peers
Comparison fields: 5 of 33
- Genetics 117
- Dermatology 88
- Hematology 110
- Pathology and Forensic Medicine 97
- Rheumatology 38
Countries citing papers authored by Sara Barulli
This map shows the geographic impact of Sara Barulli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Barulli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Barulli more than expected).
Fields of papers citing papers by Sara Barulli
This network shows the impact of papers produced by Sara Barulli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Barulli. The network helps show where Sara Barulli may publish in the future.
Co-authors
The 25 scholars most cited alongside Sara Barulli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 103 | |
| 2 | Low dose interferon-alpha2b combined with PUVA is an effective treatment of early stage mycosis fungoides: results of a multicenter study. Cutaneous-T Cell Lymphoma Multicenter Study Group. | 1999 | 48 |
| 3 | 2005 | 44 | |
| 4 | 2008 | 34 | |
| 5 | 2021 | 15 | |
| 6 | 2013 | 11 | |
| 7 | 2015 | 6 | |
| 8 | 2012 | 4 | |
| 9 | 2006 | 4 | |
| 10 | 2005 | 3 | |
| 11 | [Biologic aspects and clinical use of granulocyte growth factor]. | 1995 | 1 |
| 12 | 2013 | 1 |
About Sara Barulli
Sara Barulli is a scholar working on Pathology and Forensic Medicine, Oncology, Hematology, Genetics and Immunology, having authored 12 papers that have together received 274 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (6 papers), Acute Myeloid Leukemia Research (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), Viral-associated cancers and disorders (2 papers), Multiple Myeloma Research and Treatments (2 papers), Cutaneous lymphoproliferative disorders research (2 papers) and CNS Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Genetics (117 citations), Dermatology (88 citations), Hematology (110 citations), Pathology and Forensic Medicine (97 citations) and Rheumatology (38 citations). Sara Barulli has collaborated with scholars based in Italy, Taiwan and Canada. Frequent co-authors include Giuseppe Visani, Alessandro Isidori, Giovanni Barosi, Marie‐Caroline Le Bousse‐Kerdilès, Antonietta Falcone, S Gentili, Dominique Bordessoule, Giuliano Brandozzi, Alessandro Pecci and Brigitte Dupriez. Their work appears in journals such as European Journal Of Haematology, Blood, Frontiers in Oncology, Acta Haematologica and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.